Clinical Trial

Polymeric Micellar Paclitaxel-Based Combination Therapy for Advanced Biliary Tract Cancer

Study acronym: PILOT-BTC
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated August 6, 2026 (before its estimated August 12, 2026 completion). Its status may not reflect the trial's current state.
Summary
After the standard first-line treatment, the treatment regimen was adjusted to a paclitaxel polymer micellar-based immunotherapy combination regimen
Protocol Amendment History 5 changes
critical Enrollment closed, study ongoing 2026-08-07
critical Primary endpoint(s) modified 2026-08-07
notable Enrollment reduced: 100 -> 61 participants 2026-08-07
notable Primary completion pushed: 2025-12-31 -> 2026-08-12 2026-08-07
minor Completion pushed: 2026-07-01 -> 2027-12-07 2026-08-07
Trial Details
NCT Number NCT07159204
Lead Sponsor Peking Union Medical College Hospital
Conditions Biliary Tract Cancer (BTC)
Enrollment 61 participants
Start Date 2024-08-07
Primary Completion 2026-08-12 (estimated)
Study Completion 2027-12-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-06